European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Date of authorisation: 20/09/2006, Revision: 52, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2025 - 16:50

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Date of authorisation: 20/09/2006, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2025 - 16:40

Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2025 - 15:41

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Date of refusal: 24/09/2025, Status: Refused

Submitted by Anonymous (not verified) on 20 October 2025 - 15:40

Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Date of refusal: 24/09/2025, Status: Refused

Human medicines European public assessment report (EPAR): Vueway, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2025 - 15:29

Human medicines European public assessment report (EPAR): Vueway, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 31, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2025 - 15:23

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 31, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More